Literature DB >> 12679940

Analysis of gene expression profile of pancreatic carcinoma using cDNA microarray.

Zhi-Jun Tan1, Xian-Gui Hu, Gui-Song Cao, Yan Tang.   

Abstract

AIM: To identify new diagnostic markers and drug targets, the gene expression profiles of pancreatic cancer were compared with that of adjacent normal tissues utilizing cDNA microarray analysis.
METHODS: cDNA probes were prepared by labeling mRNA from samples of six pancreatic carcinoma tissues with Cy5-dUTP and mRNA from adjacent normal tissues with Cy3-dUTP respectively through reverse transcription. The mixed probes of each sample were then hybridized with 12 800 cDNA arrays (12 648 unique human cDNA sequences), and the fluorescent signals were scanned by ScanArray 3 000 scanner (General Scanning, Inc.). The values of Cy5-dUTP and Cy3-dUTP on each spot were analyzed and calculated by ImaGene 3.0 software (BioDiscovery, Inc.). Differentially expressed genes were screened according to the criterion that the absolute value of natural logarithm of the ratio of Cy5-dUTP to Cy3-dUTP was greater-than 0.69.
RESULTS: Among 6 samples investigated, 301 genes, which accounted for 2.38 % of genes on the microarry slides, exhibited differentially expression at least in 5. There were 166 over-expressed genes including 136 having been registered in Genebank, and 135 under-expressed genes including 79 in Genebank in cancerous tissues.
CONCLUSION: Microarray analysis may provide invaluable information on disease pathology, progression, resistance to treatment, and response to cellular microenvironments of pancreatic carcinoma and ultimately may lead to improving early diagnosis and discovering innovative therapeutic approaches for cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679940      PMCID: PMC4611457          DOI: 10.3748/wjg.v9.i4.818

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

1.  Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study.

Authors:  Mimoun Nejjari; Zakia Hafdi; Géraldine Gouysse; Michelangelo Fiorentino; Olivier Béatrix; Jérôme Dumortier; Céline Pourreyron; Chiara Barozzi; Antonia D'errico; Walter F Grigioni; Jean-Yves Scoazec
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

2.  Adhesion molecules in human pancreatic cancer.

Authors:  Adrien A Tempia-Caliera; Laszlo Zs Horvath; Arthur Zimmermann; Tibor T Tihanyi; Murray Korc; Helmut Friess; Markus W Büchler
Journal:  J Surg Oncol       Date:  2002-02       Impact factor: 3.454

Review 3.  Extracellular matrix regulation of drug resistance in small-cell lung cancer.

Authors:  Robert C Rintoul; Tariq Sethi
Journal:  Clin Sci (Lond)       Date:  2002-04       Impact factor: 6.124

4.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.

Authors:  J L Cmarik; H Min; G Hegamyer; S Zhan; M Kulesz-Martin; H Yoshinaga; S Matsuhashi; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Lumican and decorin are differentially expressed in human breast carcinoma.

Authors:  E Leygue; L Snell; H Dotzlaw; S Troup; T Hiller-Hitchcock; L C Murphy; P J Roughley; P H Watson
Journal:  J Pathol       Date:  2000-11       Impact factor: 7.996

6.  Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription.

Authors:  D Guardavaccaro; G Corrente; F Covone; L Micheli; I D'Agnano; G Starace; M Caruso; F Tirone
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Basaloid squamous carcinoma of esophagus:a clinicopathological, immunohistochemical and electron microscopic study of sixteen cases.

Authors:  Xin-Hua Zhang; Gui-Qin Sun; Xiao-Jun Zhou; Hui-Fang Guo; Tai-He Zhang
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

8.  Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells.

Authors:  Yue Ping Lu; Toshiyuki Ishiwata; Goro Asano
Journal:  J Pathol       Date:  2002-03       Impact factor: 7.996

9.  Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomas.

Authors:  Toru Takano; Yukiko Hasegawa; Akira Miyauchi; Fumio Matsuzuka; Hiroshi Yoshida; Kanji Kuma; Nobuyuki Amino
Journal:  Jpn J Clin Oncol       Date:  2002-07       Impact factor: 3.019

10.  Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma.

Authors:  Shona H Lang; Catherine Hyde; Ian N Reid; Ian S Hitchcock; Claire A Hart; A A Gordon Bryden; Jean-Marie Villette; Michael J Stower; Norman J Maitland
Journal:  Prostate       Date:  2002-09-01       Impact factor: 4.104

View more
  20 in total

1.  Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer.

Authors:  Sally E Dowen; Tatjana Crnogorac-Jurcevic; Rathi Gangeswaran; Mikkel Hansen; Jyrki J Eloranta; Vipul Bhakta; Teresa A Brentnall; Jutta Lüttges; Gunther Klöppel; Nick R Lemoine
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

2.  Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers.

Authors:  Randy S Haun; Charles M Quick; Eric R Siegel; Ilangovan Raju; Samuel G Mackintosh; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

3.  Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples.

Authors:  Henrik Laurell; Michele Bouisson; Philippe Berthelemy; Philippe Rochaix; Sebastien Dejean; Philippe Besse; Christiane Susini; Lucien Pradayrol; Nicole Vaysse; Louis Buscail
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

4.  Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival.

Authors:  Vijaya Ramachandran; Thiruvengadam Arumugam; Huamin Wang; Craig D Logsdon
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

5.  Effects of bile acids on proliferation and ultrastructural alteration of pancreatic cancer cell lines.

Authors:  Zheng Wu; Yi Lü; Bo Wang; Chang Liu; Zuo-Ren Wang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

6.  Identifying Biomarkers and Drug Targets Using Systems Biology Approaches for Pancreatic Cancer.

Authors:  Yi Tan; Lucio Miele; Fazlul H Sarkar; Zhiwei Wang
Journal:  Pancreat Disord Ther       Date:  2012-12-06

7.  Overexpression of annexin 1 in pancreatic cancer and its clinical significance.

Authors:  Xiao-Feng Bai; Xiao-Guang Ni; Ping Zhao; Shang-Mei Liu; Hui-Xin Wang; Bing Guo; Lan-Ping Zhou; Fang Liu; Jin-Sheng Zhang; Kun Wang; Yong-Qiang Xie; Yong-Fu Shao; Xiao-Hang Zhao
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

8.  Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer.

Authors:  G Feldmann; N Habbe; S Dhara; S Bisht; H Alvarez; V Fendrich; R Beaty; M Mullendore; C Karikari; N Bardeesy; M M Ouellette; W Yu; A Maitra
Journal:  Gut       Date:  2008-05-30       Impact factor: 23.059

9.  Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma.

Authors:  Hai Song; Shuang-Luo Xia; Cheng Liao; Yi-Liang Li; Yi-Fei Wang; Tsai-Ping Li; Mu-Jun Zhao
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 10.  Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives.

Authors:  Robert Grützmann; Hans Detlev Saeger; Jutta Lüttges; Hans Konrad Schackert; Holger Kalthoff; Günter Klöppel; Christian Pilarsky
Journal:  Int J Colorectal Dis       Date:  2004-01-24       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.